Duke University’s Duke Clinical Research Institute (DCRI) has been selected by Oxygen Biotherapeutics, a pharmaceutical company, to conduct the Phase III clinical trial of the company’s newly acquired compound, levosimendan. ...
Guerbet announced that Novation has awarded a new agreement for Dotarem (gadoterate meglumine) injection. Dotarem injection is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain ...
Tags: Novation, Dotarem injection, Guerbet
AMAG Pharmaceuticals has received a notice of three-month extension from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) for Feraheme (ferumoxytol) injection to be used for intravenous (IV) therapy. ...
Tags: AMAG Pharma, Intravenous Use
Bracco Diagnostics has obtained the US Food and Drug Administration (FDA) clearance for use of its MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, in magnetic resonance angiography (MRA), designed to evaluate adults with known or ...
Tags: FDA, Bracco, clearance, MultiHance injection, MRA
The Bracco Diagnostics has gained FDA approval for the use of MultiHance(gadobenate dimeglumine)injection,529mg/ml,in magnetic resonance angiography(MRA)to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive ...